Hip and knee implants are a big market -- according to Smith & Nephew's (NYSE:SNN) 2013 annual report, worth $14 billion last year. And given that the market has seen strong growth, with Medicare-covered knee replacement surgeries growing by 162% from 1991 to 2010, it's time to consider what investments might be most attractive in this market -- particularly given that most of them pay a dividend. So, Smith & Nephew? Zimmer (UNKNOWN:ZMH.DL)? Stryker (NYSE:SYK)? Johnson & Johnson (NYSE:JNJ)?

In the video below, Motley Fool health care analysts Michael Douglass and David Williamson give their take. 

David Williamson owns shares of Johnson & Johnson. Michael Douglass has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson and Zimmer Holdings. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.